Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR Trial

Viviany R. Taqueti, Amil M. Shah, Brendan M. Everett, Aruna D. Pradhan, Gregory Piazza, Courtney Bibbo, Jon Hainer, Victoria Morgan, Ana Carolina do A. H. de Souza, Hicham Skali, Ron Blankstein, Sharmila Dorbala, Samuel Z. Goldhaber, Michel R. Le May, Benjamin J.W. Chow, Robert A. deKemp, Fadi G. Hage, Rob S. Beanlands, Peter Libby, Robert J. GlynnScott D. Solomon, Paul M. Ridker, Marcelo F. Di Carli

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Inflammation is a key determinant of cardiovascular outcomes, but its role in heart failure is uncertain. In patients with cardiometabolic disease enrolled in the prospective, multicenter ancillary study of CIRT (Cardiovascular Inflammation Reduction Trial), CIRT-CFR (Coronary Flow Reserve to Assess Cardiovascular Inflammation), impaired coronary flow reserve was independently associated with increased inflammation and myocardial strain despite well-controlled lipid, glycemic, and hemodynamic profiles. Inflammation modified the relationship between CFR and myocardial strain, disrupting the association between cardiac blood flow and function. Future studies are needed to investigate whether an early inflammation-mediated reduction in CFR capturing microvascular ischemia may lead to heart failure in patients with cardiometabolic disease.

Original languageEnglish (US)
Pages (from-to)141-151
Number of pages11
JournalJACC: Basic to Translational Science
Volume8
Issue number2
DOIs
StatePublished - Feb 2023
Externally publishedYes

Keywords

  • cardiometabolic disease
  • cardiovascular trial coronary flow reserve
  • coronary microvascular dysfunction
  • heart failure
  • inflammation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Coronary Flow Reserve, Inflammation, and Myocardial Strain: The CIRT-CFR Trial'. Together they form a unique fingerprint.

Cite this